Paper · 2005
Second-generation antipsychotics for schizophrenia: a review of clinical pharmacology and medication-associated side effects.
PubMed, 42(1), 51–60 · Published 1 January 2005
In brief
“Second-generation antipsychotics for schizophrenia: a review of clinical pharmacology and medication-associated side effects.” is a 2005 paper by Robert R. Conley and Deanna L. Kelly, published in PubMed. OpenAlex counts 47 citations as of 20 November 2026. The publisher's version is not open access, and OpenAlex records no free legal copy.
- Citations
- 47
- Most cited in
- 2020 (6)
- Field-weighted impact
- 1.82
- References
- 53
- Authors
- 2
Abstract
Second-generation antipsychotics (SGAs) are replacing traditional antipsychotics as first line therapy for the treatment of schizophrenia. While recent evidence suggests similar efficacy with low dose conventional antipsychotics, much of the advantage favoring SGAs comes from the fact that there are fewer extrapyramidal side effects (EPS) at effective doses with these drugs. As a medication class… Read the full abstract at the publisher.
Excerpt. This paper is not open access.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Conley, R. R., & Kelly, D. L. (2005). Second-generation antipsychotics for schizophrenia: a review of clinical pharmacology and medication-associated side effects. PubMed, 42(1), 51–60. https://pubmed.ncbi.nlm.nih.gov/16134407
MLA 9
Conley, Robert R., and Deanna L. Kelly. “Second-generation antipsychotics for schizophrenia: a review of clinical pharmacology and medication-associated side effects.” PubMed, vol. 42, no. 1, 2005, pp. 51–60. https://pubmed.ncbi.nlm.nih.gov/16134407.
Chicago
Conley, Robert R. and Deanna L. Kelly. 2005. “Second-generation antipsychotics for schizophrenia: a review of clinical pharmacology and medication-associated side effects.” PubMed 42 (1): 51–60. https://pubmed.ncbi.nlm.nih.gov/16134407.
Harvard
Conley, R. R. and Kelly, D. L. (2005) ‘Second-generation antipsychotics for schizophrenia: a review of clinical pharmacology and medication-associated side effects.’, PubMed, 42(1), pp. 51–60. Available at: https://pubmed.ncbi.nlm.nih.gov/16134407.
IEEE
R. R. Conley and D. L. Kelly, “Second-generation antipsychotics for schizophrenia: a review of clinical pharmacology and medication-associated side effects.,” PubMed, vol. 42, no. 1, pp. 51–60, 2005.
BibTeX
@article{conley2005second,
title = {{Second-generation antipsychotics for schizophrenia: a review of clinical pharmacology and medication-associated side effects.}},
author = {Conley, Robert R. and Kelly, Deanna L.},
journal = {PubMed},
year = {2005},
volume = {42},
number = {1},
pages = {51--60},
url = {https://pubmed.ncbi.nlm.nih.gov/16134407}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Citations by year
| Year | Citations | Share of the best year |
|---|---|---|
| 2013 | 3 | |
| 2014 | 4 | |
| 2015 | 2 | |
| 2016 | 1 | |
| 2018 | 1 | |
| 2019 | 3 | |
| 2020 | 6 | |
| 2022 | 2 | |
| 2024 | 1 | |
| 2025 | 1 |
Its field-weighted citation impact is 1.82: it has been cited 1.82 times as often as the average work of the same field, type and year (1.00 is the world average).
Topic and keywords
Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- atypical antipsychotics
- schizophrenia
- clinical pharmacology
- extrapyramidal symptoms
- clozapine
- receptor binding
- structure-activity relationship
- adverse drug reactions
Work with this paper
Most-cited papers in Medicine
- Yaşlı Kadınlarda Üreme SağlığıDemet Kokanalı, Yaprak Engin Üstün · Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi · 2019 · 169,630 citations
- Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 CountriesHyuna Sung, Adalberto M. Filho, Mathieu Laversanne and 5 more · CA A Cancer Journal for Clinicians · 2021 · 119,885 citations
- “Mini-mental state”Marshal F. Folstein, Susan E. Folstein, Paul R. McHugh · Journal of Psychiatric Research · 1975 · 90,424 citations
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countriesFreddie Bray, Jacques Ferlay, Isabelle Soerjomataram and 3 more · CA A Cancer Journal for Clinicians · 2018 · 87,396 citations
- Hallmarks of Cancer: The Next GenerationDouglas Hanahan, Robert A. Weinberg · Cell · 2011 · 69,758 citations
Questions about this paper
How do I cite this paper in APA style?
Conley, R. R., & Kelly, D. L. (2005). Second-generation antipsychotics for schizophrenia: a review of clinical pharmacology and medication-associated side effects. PubMed, 42(1), 51–60. https://pubmed.ncbi.nlm.nih.gov/16134407
How many times has this paper been cited?
47 times, according to OpenAlex on 20 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
OpenAlex records no free legal copy. Check your library's access, the authors' pages or a repository, or ask the corresponding author for a copy.
Who wrote this paper?
Robert R. Conley, Deanna L. Kelly.
Bibliographic data from OpenAlex (CC0), last checked 20 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.